Comparison of two techniques for assessing pancreatic islet viability : flow cytometry and fluorescein diacetate/propidium iodide staining
dc.contributor.author | Lemos, Natália Emerim | pt_BR |
dc.contributor.author | Dieter, Cristine | pt_BR |
dc.contributor.author | Farias, Mariela Granero | pt_BR |
dc.contributor.author | Rheinheimer, Jakeline | pt_BR |
dc.contributor.author | Souza, Bianca Marmontel de | pt_BR |
dc.contributor.author | Bauer, Andrea Carla | pt_BR |
dc.contributor.author | Crispim, Daisy | pt_BR |
dc.date.accessioned | 2022-01-07T04:27:00Z | pt_BR |
dc.date.issued | 2021 | pt_BR |
dc.identifier.issn | 2357-9730 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/233833 | pt_BR |
dc.description.abstract | Introduction: The success of islet transplantation for patients with unstable type 1 diabetes mellitus depends, in part, on the number of isolated islets and their quality, which is assessed by functional and viability tests. The test currently employed to evaluate islet viability, used by the Collaborative Islet Transplant Registry to release products for transplantation, is fluorescein diacetate/propidium iodide (FDA/PI) staining. However, the efficacy of this method relies on researcher experience; in this context, a quantitative method may be useful. The aim of this study was to compare islet viability as assessed by flow cytometry and the FDA/PI assay. Methods: Viability was analyzed in islets isolated from 10 male Wistar rats. Upon FDA/PI staining, 50 islets from each animal were analyzed under fluorescence microscopy by two well-trained researchers. For flow cytometry, islets were dispersed and 100 000 single cells were incubated with the 7-amino-actinomycin D (7AAD) fluorophore (dyes necrotic and late apoptotic cells) and the Annexin V-APC antibody (marks early apoptotic cells). Results: A moderate correlation was found between techniques (r = 0.6; p = 0.047). The mean islet viability measured by flow cytometry was higher than that estimated using FDA/PI staining (95.5 ± 1.4% vs 89.5 ± 5.0%; p = 0.002). Conclusions: Although flow cytometry is more expensive and time-consuming than FDA/PI staining, it is a quantitative technique with greater reproducibility that is less subject to inter-observer variability than FDA/PI. Therefore, flow cytometry appears to be the technique of choice when aiming for a more precise determination of islet viability. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | Clinical and biomedical research. Porto Alegre. Vol. 41, no. 4 (2021), p. 325-331 | pt_BR |
dc.rights | Open Access | en |
dc.subject | Islet transplantation | en |
dc.subject | Transplante das ilhotas pancreáticas | pt_BR |
dc.subject | Islet isolation | en |
dc.subject | Ilhotas pancreáticas | pt_BR |
dc.subject | Viability | en |
dc.subject | Separação celular | pt_BR |
dc.subject | Sobrevivência celular | pt_BR |
dc.subject | Flow cytometry | en |
dc.subject | Citometria de fluxo | pt_BR |
dc.title | Comparison of two techniques for assessing pancreatic islet viability : flow cytometry and fluorescein diacetate/propidium iodide staining | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 001135178 | pt_BR |
dc.type.origin | Nacional | pt_BR |
Este item está licenciado na Creative Commons License
-
Artigos de Periódicos (40175)Ciências da Saúde (10740)